Triple-Hormone-Receptor Agonist Retatrutide for Obesity
- PMID: 37888925
- DOI: 10.1056/NEJMc2310645
Triple-Hormone-Receptor Agonist Retatrutide for Obesity
Comment on
-
Triple-Hormone-Receptor Agonist Retatrutide for Obesity - A Phase 2 Trial.N Engl J Med. 2023 Aug 10;389(6):514-526. doi: 10.1056/NEJMoa2301972. Epub 2023 Jun 26. N Engl J Med. 2023. PMID: 37366315 Clinical Trial.
References
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical